期刊文献+

pIRES2-EGFP-LR真核表达载体的构建及其在293T细胞中的表达

Construction of eukaryotic expression plasmid pIRES2-EGFP-LR and its expression in 293T cells
在线阅读 下载PDF
导出
摘要 为探讨层黏蛋白受体的生理功能及其在疾病发生、发展过程中的作用,以培养的SD大鼠大脑皮质神经元的总RNA为模板,运用RT-PCR方法扩增了SD大鼠层黏蛋白受体基因。将其克隆到pMD18-T载体中,经酶切纯化后再将其亚克隆到带有加强型绿色荧光蛋白报告基因的pIRES2-EGFP真核表达载体中,对重组质粒pIRES2-EGFP-LR进行酶切和测序鉴定后,采用阳离子脂质体转染法将重组质粒转染到293T细胞,荧光显微镜和激光共聚焦显微镜观察其表达情况。结果表明,真核表达载体pIRES2-EGFP-LR构建成功并可以在293T细胞中表达。该表达载体可以作为研究层黏蛋白受体生理功能的重要工具。 To explore the physiologic function of laminin receptor (LR) and its role in the development of diseases,a LR gene was amplified by RT-PCR with the total RNA extracted of the cultured cortical neurons of SD rats as template. To construct pMD18-T-LR, the amplified gene was cloned into the vector pMD18-T. The LR gene from pMD18-T-LR digested by restriction enzymes Bgl Ⅱ +SaiⅠ was cloned into the eukaryotic expression vector plRES2-EGFP with the reported gene EGFP (enhanced green fluorescence protein). The positive recombinant was deisignated with pIRES2-EGFP-LR. After being identified by restriction enzyme digestion and sequencing, the recombinant pIRES2-EGFP-LR was transfected into 293T cells by liposomes. The expression of the recombinant pIRES2-EGFP-LR in the 293T cells was observed by fluorescence microscope and laser scanning confocal microscope. The results showed that the LR of pIRES2-EGFP-LR was successfully expressed in the 293T cells.
出处 《中国兽医科学》 CAS CSCD 北大核心 2009年第9期817-820,共4页 Chinese Veterinary Science
基金 国家自然科学基金项目(30700603) 广东省自然科学基金项目(7300744) 教育部"长江学者和创新团队发展计划"创新团队项目(IRT0723) 华南农业大学校长基金项目[152(3)]
关键词 层黏蛋白受体 真核表达载体 转染 laminin receptor eukaryotic expression vector transfection
  • 相关文献

参考文献2

二级参考文献26

  • 1William P, The role of interleukin-1 receptor antagonist in the prevention and treatment of disease. Mod Rheumatol, 2003, 13: 1-6.
  • 2Mao XQ, Kawai M, Yamashita T, Enomoto T, Dake Y, Sasaki S, Imbalance production between interleukin- 1b (IL-1b) and IL-1 receptor antagonist (IL-1ra) in bronchial asthma. Biochem Biophys Res Commun, 2000, 276: 607-612.
  • 3Schmitz N, Kurrer M & Kopf M, The IL-1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma model. Eur J Immunol, 2003, 33: 991-1000.
  • 4Dinarello CA, Interleukin-1 and Interleukin-1 antagonism. Blood, 1991, 77(8): 1 627-1552.
  • 5Gohlke H, Illig T & Bahnweg M, Association of the inter- leukin-1 receptor antagonist gene with asthma. Am J Respir Crit Care Med, 2004, 169:1 217- 1 223.
  • 6Evans I, Dower SK & Francis SE, Action of intracellular IL-1Ra (Type 1) is independent of the IL-1 intracellular signaling pathway, Cytokine, 2006, 33(5): 274- 280.
  • 7Keane AM, Miyazaki D, Liu G, Dekaris I, Ono S, & Dana MR, Prevention of allergic eye disease by treatment with IL-1 receptor antagonist. Invest Ophth-almol Vis Sci, 1999, 40: 3041-3046.
  • 8Okada S, Inoue H, Yamauchi K, Iijima H, Ohkawara Y & Takishima T, Potential role of interleukin-1 in allergen induced late asthmatic reactions in guinea pigs: suppressive effect of interleukin-1 receptor antagonist on late asthmatic reaction. J Allergy Clin Immunol, 1995, 95: 1 236-1 245.
  • 9Platts TA, The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med, 2001, 164 (8) : s125.
  • 10Rosenwasser LJ, New immunopharmacologic approaches to asthma : role of cytokine antagonism. J Allergy Clin Immunol, 2000, 105: 586-591.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部